Table 1.
JBS2 | QRISK2 | ASSIGN | JES5a | WHO | QRISK Lifetime | |
---|---|---|---|---|---|---|
Data | Based on FHS and Framingham Offspring Study | QRESEARCH database | SHHEC prospective study | 12 pooled prospective studies from 11 European countries | Different method not based on prospective data | QRESEARCH database |
Population and sample type | General population, Framingham Mass, U.S. Volunteers | Health records of general practice attendees-not random | Random sample from general population in Scotland | Random samples from general population, some occupational cohorts | Not applicable | Health records of general practice attendees-not random |
Sample size | 3969 men 4522 women |
2.29 million | 6540 men 6757 women |
117,098 men 88,080 women |
Not applicable | 2.29 million |
Calculates | 10-year risk of CVD events, risk age | 10-year risk of CHD, stroke and TIA | 10-year risk of CVD events | 10-yr risk of CVD mortality | 10-year risk of CVD events | CVD risk over a person's remaining lifetime |
Age (years) | 30–75 | 30–84 | 30–74 | 40–65 | 20–75 | 30–84 |
Variables | Age, sex, SBP, DBP, TC, HDL, TC/HDL, TG, smoking, glucose, central obesity, S.A origin, FHx, LVH | Sex, age, TC/HDL, SBP, smoking status, diabetes, area-based index of deprivation, family history, BMI, anti-hypertensive treatment, CKD, AF, RA | Current age, gender, FHx, diabetes, cigarettes smoked daily, SBP, TC, HDL, Scottish postcode | Age, gender, smoking, SBP, TC, HDL | Age, gender, smoking, SBP ± TC, diabetes | Sex, age, TC/HDL, SBP, smoking status, diabetes, area-based index of deprivation, family history, BMI, anti-hypertensive treatment, previous CVD, CKD, AF, RA |
Formats | Color charts, online calculator | Online calculator | Online calculator | Color-coded charts, Heart Score-online and CD electronic versions | Color-coded charts | Online calculator |
Guidelines that recommend its use | JBS2 | NICE guidelines on lipid modification | SIGN | European guidelines on CVD prevention | WHO guidelines on CVD prevention | JBS3 calculator (not yet published) |
AF, atrial fibrillation; BP, blood pressure; CHD, coronary heart disease; CKD, chronic kidney disease; CVD, cardiovascular disease (heart attack, angina, stroke or transient ischemic attack); DBP, diastolic blood pressure; FHS, Framingham Heart Study; FHx, family history of premature CVD; HDL, high density lipoprotein cholesterol; JBS, Joint British Societies; LDL, low density lipoprotein cholesterol; NICE, National Institute for Health and Clinical Excellence; S.A origin, South Asian origin; SBP, systolic blood pressure; SHHEC, Scottish Heart Health Extended Cohort; SIGN, Scottish Intercollegiate Network; RA, rheumatoid arthritis; TC, total cholesterol; TG, triglyceride; TIA, transient ischemic attack.
The total risk is for fatal CVD.
Adapted from: Cooney et al. (2009).32